Are Medications for Alcoholism Underutilized? An Analysis of Private-Sector and Medicaid Claims

Drug Benefit Trends

Volumn 16, Issue 3, 2004, Pages 154-158

  Mark, Tami L ^a  

^a MEDSTAT GROUP   (United States)

Author keywords

Alcoholism; Disulfiram; Naltrexone; Psychotropic medications

Indexed keywords

ANTIDEPRESSANT AGENT; DISULFIRAM; NALTREXONE;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; ARTICLE; CHILD; DRUG COST; DRUG USE; FEMALE; GROUPS BY AGE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MENTAL HEALTH SERVICE; NATIONAL HEALTH INSURANCE; PRESCRIPTION; PRIVATE HEALTH INSURANCE;

EID: 1642298044     PISSN: 10805826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Zuvekas SH. Trends in mental health services use and spending, 1987-1996. Health Aff (Millwood). 2001;20:214-224.
2. Olfson M, Marcus SC, Druss B, et al. National trends in the outpatient treatment of depression. JAMA. 2002;287:203-209.
3. Zito JM, Safer DJ, DosReis S, et al. Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med. 2003;157:17-25.
4. Mark TL, Coffey RM. What drove private health insurance spending on mental health and substance abuse care, 1992-1999? Health Aff (Millwood). 2003;22:165-172.
5. Saitz R, O'Malley SS. Pharmacotherapies for alcohol abuse: withdrawal and treatment. Med Clin North Am. 1997;81:881-907.
6. Monterosso JR, Flannery BA, Pettinati HM, et al. Predicting treatment response to naltrexone: the influence of craving and family history. Am J Addict. 2001;10:258-268.
7. Grant BF, Harford TC, Dawson DA, et al. Epidemiologic Bulletin No. 35: Prevalence of DSM-IV alcohol abuse and dependence: United States, 1992. Alcohol Health Res World. 1994;18:243-248.
8. Mark TL, Kranzler HR, Song X. Understanding US addiction physicians' low rate of naltrexone prescription. Drug Alcohol Depend. 2003;71:219-228.
9. Mark TL, Swait J. Using stated preference modeling to forecast the effect of medication attributes on prescriptions of alcoholism medications. Value Health. 2003;6:474-482.
10. Thomas CP, Wallack SS, Lee S, et al. Research to practice: adoption of naltrexone in alcoholism treatment. J Subst Abuse Treat, 2003;24:1-11.
11. Krystal JH, Cramer JA, Krol WF, et al. Naltrexone in the treatment of alcohol dependence. N Engl J Med. 2001;345:1734-1739.
12. Garbutt JC, West SL, Carey TS, et al. Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA. 1999;281:1318-1325.
13. Office of Applied Studies, Substance Abuse and Mental Health Services Administration. 2001 National Household Survey on Drug Abuse. Rockville, Md: Department of Health and Human Services; 2001.
14. Emrick CD, Tonigan JS, Montgomery H, Little L. Alcoholics Anonymous: What is currently known? In: McCrady BS, Miller WR, eds. Research on Alcoholics Anonymous: Opportunities and Alternatives. New Brunswick, NJ: Rutgers Center of Alcoholic Studies; 1993:41-76.
15. National Institute on Alcohol Abuse and Alcoholism. 10th Special Report to the US Congress on Alcohol and Health. Bethesda, Md: National Institutes of Health, US Dept of Health and Human Services; June 2000.